- Home
- EML vs RVNC Comparison
EML vs RVNC Comparison
Compare EML & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EML
- RVNC
- Stock Information
- Founded
- EML 1858
- RVNC 1999
- Country
- EML United States
- RVNC United States
- Employees
- EML N/A
- RVNC N/A
- Industry
- EML Industrial Machinery/Components
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- EML Consumer Discretionary
- RVNC Health Care
- Exchange
- EML Nasdaq
- RVNC Nasdaq
- Market Cap
- EML 191.3M
- RVNC 320.5M
- IPO Year
- EML N/A
- RVNC 2014
- Fundamental
- Price
- EML $27.77
- RVNC $3.09
- Analyst Decision
- EML
- RVNC Hold
- Analyst Count
- EML 0
- RVNC 9
- Target Price
- EML N/A
- RVNC $8.45
- AVG Volume (30 Days)
- EML 16.1K
- RVNC 3.6M
- Earning Date
- EML 11-01-2024
- RVNC 11-07-2024
- Dividend Yield
- EML 1.58%
- RVNC N/A
- EPS Growth
- EML N/A
- RVNC N/A
- EPS
- EML N/A
- RVNC N/A
- Revenue
- EML $284,461,286.00
- RVNC $256,945,000.00
- Revenue This Year
- EML N/A
- RVNC $11.28
- Revenue Next Year
- EML N/A
- RVNC $27.21
- P/E Ratio
- EML $13.94
- RVNC N/A
- Revenue Growth
- EML 7.70
- RVNC 25.82
- 52 Week Low
- EML $20.50
- RVNC $2.30
- 52 Week High
- EML $35.78
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- EML 40.52
- RVNC 33.47
- Support Level
- EML $28.21
- RVNC $3.06
- Resistance Level
- EML $30.72
- RVNC $3.09
- Average True Range (ATR)
- EML 1.10
- RVNC 0.11
- MACD
- EML -0.08
- RVNC 0.02
- Stochastic Oscillator
- EML 0.00
- RVNC 6.90
About EML Eastern Company (The)
The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to industrial markets. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It operates in the United States and Other Countries and generates the majority of its revenue from the United States.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.